UNSPSC 51383307: Nepafenac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0J9L7J6V8C, chemically known as benzeneacetamide, 2-amino-3-benzoyl- but generally known as nepafenac, which bears US NIH Compound Identifier 151075. European Medicines Agency schedules Nepafenac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09197MIG.

UNSPSC 51383307 Nepafenac is a Commodity code tracking pharmaceutical products, though recent state and local procurement activity under this code shows minimal alignment with the nominal scope. Nepafenac is a nonsteroidal anti-inflammatory ophthalmic agent, but the single recent opportunity on file is Seminole County, Florida's solicitation for naloxone and drug deactivation systems—a public-health emergency response product wholly unrelated to ophthalmic pharmaceuticals. The source does not support characterization of issuing-body mix, repeat buyers, or issuing-body concentration under this code; state and local procurement activity under 51383307 appears limited or misaligned with the code's stated pharmaceutical category.

Seminole County, Florida is the only jurisdiction with recent documented activity. Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB carried a response deadline of July 26, 2023. The mismatch between the code taxonomy (ophthalmic anti-inflammatory) and the actual procurement (emergency opioid-reversal and drug-disposal equipment) suggests either miscoding on the issuing body's part or limited use of 51383307 for state and local pharmaceutical contracting. The code does not show sufficient recent activity to characterize broader geographic spread or establish a stable pattern of state and local buying across multiple jurisdictions.